Greenwich LifeSciences (GLSI) Insider Trading & Ownership $10.65 -0.60 (-5.33%) As of 03/25/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Greenwich LifeSciences (NASDAQ:GLSI) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage51.67%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$2.85 MNumber OfInsiders Selling(Last 12 Months)0 Get GLSI Insider Trade Alerts Want to know when executives and insiders are buying or selling Greenwich LifeSciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address GLSI Insider Buying and Selling by Quarter Remove Ads Greenwich LifeSciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/10/2025Snehal PatelCEOBuy2,500$12.51$31,275.00 1/7/2025Snehal PatelCEOBuy1,800$13.75$24,750.00 1/2/2025Snehal PatelCEOBuy2,000$11.97$23,940.00 12/30/2024Snehal PatelCEOBuy3,200$11.12$35,584.00 11/21/2024Jaye ThompsonVPBuy1,000$12.91$12,910.00 9/26/2024Snehal PatelCEOBuy1,500$14.63$21,945.00 8/12/2024Jaye ThompsonVPBuy800$13.85$11,080.00 8/5/2024Snehal PatelCEOBuy5,500$13.18$72,490.00 8/2/2024Jaye ThompsonVPBuy1,000$15.15$15,150.00 7/23/2024Snehal PatelCEOBuy1,500$15.89$23,835.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 7/18/2024Jaye ThompsonVPBuy1,000$16.00$16,000.00 6/13/2024Snehal PatelCEOBuy174,825$14.30$2,499,997.50 4/1/2024Snehal PatelCEOBuy3,000$19.08$57,240.00 (Data available from 1/1/2013 forward) GLSI Insider Trading Activity - Frequently Asked Questions Who is on Greenwich LifeSciences's Insider Roster? The list of insiders at Greenwich LifeSciences includes Frank Joseph Daugherty, Jaye Thompson, and Snehal Patel. Learn more on insiders at GLSI. What percentage of Greenwich LifeSciences stock is owned by insiders? 51.67% of Greenwich LifeSciences stock is owned by insiders. Learn more on GLSI's insider holdings. Which Greenwich LifeSciences insiders have been buying company stock? The following insiders have purchased GLSI shares in the last 24 months: Jaye Thompson ($81,698.50), and Snehal Patel ($3,407,758.50). How much insider buying is happening at Greenwich LifeSciences? Insiders have purchased a total of 258,025 GLSI shares in the last 24 months for a total of $3,489,457.00 bought. Greenwich LifeSciences Key ExecutivesMr. Snehal S. Patel (Age 60)CEO, CFO & Director Compensation: $1.09M5 recent tradesMr. Eric Rothe (Age 48)Founder & Independent Director Compensation: $65.64kDr. Frank Joseph Daugherty M.D. (Age 73)Chief Medical Officer & Director Dr. Jaye L. Thompson Ph.D. (Age 58)Vice President Clinical & Regulatory Affairs Dr. Christine T. Fischette Ph.D. (Age 73)VP of Business Development More Insider Trading Tools from MarketBeat Related Companies CRMD Insider Trading ORGO Insider Trading SANA Insider Trading CDXC Insider Trading KALV Insider Trading MGTX Insider Trading ARVN Insider Trading RLAY Insider Trading KURA Insider Trading ORIC Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles NVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It Matters This page (NASDAQ:GLSI) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredThis Crypto Is Set to Explode in FebruaryBryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Greenwich LifeSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Greenwich LifeSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.